Retrospective evaluation of premenopausal hormone-sensitive breast cancer patients treated with adjuvant gonadotropin-releasing hormone analogue.

Journal of Clinical Oncology ◽

10.1200/jco.2014.32.15_suppl.e11542 ◽

2014 ◽

Vol 32 (15_suppl) ◽

pp. e11542-e11542

Author(s):

Ayse Demirci ◽

Necati Alkis ◽

Faysal Dane ◽

Dogan Yazilitas ◽

Ayse Durnali ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Gonadotropin Releasing Hormone ◽

Retrospective Evaluation ◽

Breast Cancer Patients ◽

Hormone Analogue ◽

Releasing Hormone ◽

Gonadotropin Releasing Hormone Analogue ◽

Hormone Sensitive

Download Full-text

Retrospective evaluation of premenopausal hormone-sensitive breast cancer patients treated with adjuvant gonadotropin-releasing hormone analogue: Anatolian Society of Medical Oncology (ASMO) study

Asia-Pacific Journal of Clinical Oncology ◽

10.1111/ajco.12685 ◽

2017 ◽

Vol 14 (2) ◽

pp. e145-e151 ◽

Author(s):

Ayşe Demirci ◽

Necati Alkış ◽

Faysal Dane ◽

Ayşe Durnalı ◽

Ömer Kamil Yazıcı ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Medical Oncology ◽

Gonadotropin Releasing Hormone ◽

Retrospective Evaluation ◽

Breast Cancer Patients ◽

Hormone Analogue ◽

Releasing Hormone ◽

Gonadotropin Releasing Hormone Analogue ◽

Hormone Sensitive

Download Full-text

Abstract PD7-10: Male-GBG54: A prospective, randomised multi-centre phase II study evaluating endocrine treatment with either tamoxifen +/- gonadotropin releasing hormone analogue (GnRHa) or an aromatase inhibitor + GnRHa in male breast cancer patients

10.1158/1538-7445.sabcs17-pd7-10 ◽

2018 ◽

Author(s):

M Reinisch ◽

S Seiler ◽

T Hauzenberger ◽

S Schmatloch ◽

HJ Strittmatter ◽

...

Keyword(s):

Breast Cancer ◽

Aromatase Inhibitor ◽

Cancer Patients ◽

Phase Ii ◽

Phase Ii Study ◽

Gonadotropin Releasing Hormone ◽

Endocrine Treatment ◽

Breast Cancer Patients ◽

Hormone Analogue ◽

Gonadotropin Releasing Hormone Analogue

Download Full-text

Final analysis of the Male-GBG54 study: A prospective, randomised multi-centre phase II study evaluating endocrine treatment with either tamoxifen +/- gonadotropin releasing hormone analogue (GnRHa) or an aromatase inhibitor + GnRHa in male breast cancer patients

Annals of Oncology ◽

10.1093/annonc/mdy424.007 ◽

2018 ◽

Vol 29 ◽

pp. viii706

Author(s):

M. Reinisch ◽

S. Seiler ◽

T. Hauzenberger ◽

S. Schmatloch ◽

H.-J. Strittmatter ◽

...

Keyword(s):

Breast Cancer ◽

Aromatase Inhibitor ◽

Cancer Patients ◽

Phase Ii Study ◽

Final Analysis ◽

Gonadotropin Releasing Hormone ◽

Endocrine Treatment ◽

Breast Cancer Patients ◽

Hormone Analogue ◽

Gonadotropin Releasing Hormone Analogue

Download Full-text

Prediction of ovarian function recovery after ovarian protection with gonadotropin-releasing hormone agonist during chemotherapy in young breast cancer patients

10.26226/morressier.5912d9ebd462b802923862c7 ◽

2017 ◽

Author(s):

Dong-Yun Lee

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Ovarian Function ◽

Gonadotropin Releasing Hormone ◽

Breast Cancer Patients ◽

Releasing Hormone ◽

Gonadotropin Releasing Hormone Agonist ◽

Ovarian Protection ◽

Function Recovery ◽

Young Breast Cancer

Download Full-text

Prediction of ovarian function recovery in young breast cancer patients after protection with gonadotropin-releasing hormone agonist during chemotherapy

Breast Cancer Research and Treatment ◽

10.1007/s10549-018-4863-2 ◽

2018 ◽

Vol 171 (3) ◽

pp. 649-656 ◽

Author(s):

Dong-Yun Lee ◽

Yeon Hee Park ◽

Jeong Eon Lee ◽

DooSeok Choi

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Ovarian Function ◽

Gonadotropin Releasing Hormone ◽

Breast Cancer Patients ◽

Releasing Hormone ◽

Gonadotropin Releasing Hormone Agonist ◽

Function Recovery ◽

Young Breast Cancer

Download Full-text

Gonadotropin-releasing hormone analogues for the prevention of chemotherapy-induced premature ovarian failure in breast cancer patients

Minerva Obstetrics and Gynecology ◽

10.23736/s0026-4784.17.04067-9 ◽

2017 ◽

Vol 69 (4) ◽

Author(s):

Benedetta Conte ◽

Lucia Del Mastro

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Premature Ovarian Failure ◽

Ovarian Failure ◽

Gonadotropin Releasing Hormone ◽

Breast Cancer Patients ◽

Releasing Hormone

Download Full-text

Gonadotropin-Releasing Hormone Analogue for Premenopausal Women With Breast Cancer—Reply

JAMA ◽

10.1001/jama.2011.1517 ◽

2011 ◽

Vol 306 (16) ◽

pp. 1760

Author(s):

Lucia Del Mastro

Keyword(s):

Breast Cancer ◽

Premenopausal Women ◽

Gonadotropin Releasing Hormone ◽

Hormone Analogue ◽

Releasing Hormone ◽

Gonadotropin Releasing Hormone Analogue

Download Full-text

Faculty Opinions recommendation of Effect of the gonadotropin-releasing hormone analogue triptorelin on the occurrence of chemotherapy-induced early menopause in premenopausal women with breast cancer: a randomized trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.12231956.14320064 ◽

2011 ◽

Author(s):

Frank Meyskens ◽

Krish Tewari

Keyword(s):

Breast Cancer ◽

Randomized Trial ◽

Premenopausal Women ◽

Gonadotropin Releasing Hormone ◽

Hormone Analogue ◽

Early Menopause ◽

Releasing Hormone ◽

Gonadotropin Releasing Hormone Analogue

Download Full-text

Effect of the Gonadotropin-Releasing Hormone Analogue Triptorelin on the Occurrence of Chemotherapy-Induced Early Menopause in Premenopausal Women With Breast Cancer

JAMA ◽

10.1001/jama.2011.991 ◽

2011 ◽

Vol 306 (3) ◽

Author(s):

Lucia Del Mastro ◽

Luca Boni ◽

Andrea Michelotti ◽

Teresa Gamucci ◽

Nina Olmeo ◽

...

Keyword(s):

Breast Cancer ◽

Premenopausal Women ◽

Gonadotropin Releasing Hormone ◽

Hormone Analogue ◽

Early Menopause ◽

Releasing Hormone ◽

Gonadotropin Releasing Hormone Analogue

Download Full-text

Prediction of Successful Ovarian Protection Using Gonadotropin-Releasing Hormone Agonists During Chemotherapy in Young Estrogen Receptor-Negative Breast Cancer Patients

Frontiers in Oncology ◽

10.3389/fonc.2020.00863 ◽

2020 ◽

Vol 10 ◽

Author(s):

Dong-Yun Lee ◽

Ji-Yeon Kim ◽

Jonghan Yu ◽

Seok Won Kim

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Cancer Patients ◽

Gonadotropin Releasing Hormone ◽

Breast Cancer Patients ◽

Releasing Hormone ◽

Ovarian Protection ◽

Estrogen Receptor Negative

Download Full-text